梅花生物
(600873)
| 流通市值:194.89亿 | | | 总市值:194.89亿 |
| 流通股本:28.04亿 | | | 总股本:28.04亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,347,558,801.9 | 2,877,767,910.42 | 2,641,777,808.24 | 4,288,171,778.59 |
| 交易性金融资产 | 3,243,525,835.48 | 1,977,052,675.2 | 1,049,911,128.18 | 1,140,377,416.7 |
| 衍生金融资产 | 3,057,904.75 | 2,181,653.58 | 270,800 | 2,061,300 |
| 应收票据及应收账款 | 755,275,778.81 | 685,879,789.52 | 676,585,265.61 | 684,913,644.65 |
| 其中:应收票据 | 66,258,756.79 | 36,626,560.85 | 79,132,785.22 | 107,542,558.59 |
| 应收账款 | 689,017,022.02 | 649,253,228.67 | 597,452,480.39 | 577,371,086.06 |
| 应收款项融资 | 43,313,273.85 | 32,134,493.66 | 114,724,414.09 | 17,978,363 |
| 预付款项 | 116,036,004.35 | 142,397,572.45 | 206,232,132.5 | 171,884,582.59 |
| 其他应收款合计 | 14,733,095.37 | 62,537,139.77 | 28,999,693.51 | 70,477,156.58 |
| 其中:应收利息 | 1,181,250 | 2,362,500 | 1,989,512.07 | 1,575,000 |
| 应收股利 | - | - | 1,395,866.49 | 1,395,866.49 |
| 存货 | 2,692,597,511.28 | 3,996,122,827.78 | 4,597,631,588.86 | 3,021,627,701.05 |
| 一年内到期的非流动资产 | 610,384,527.5 | 606,208,384.81 | 182,291,406.52 | 75,575,625.48 |
| 其他流动资产 | 401,616,129.44 | 376,523,005.53 | 320,808,927.69 | 214,731,083.57 |
| 流动资产合计 | 10,228,098,862.73 | 10,758,805,452.72 | 9,819,233,165.2 | 9,687,798,652.21 |
| 非流动资产: | | | | |
| 债权投资 | 10,500,000 | 10,500,000 | 10,500,000 | 10,500,000 |
| 长期应收款 | 147,440.7 | 224,781.42 | 228,934.44 | 233,244.15 |
| 长期股权投资 | 2,327,091.01 | 2,635,435.8 | 4,096,791.78 | 4,757,925.21 |
| 其他权益工具投资 | 230,180,305 | 229,089,650 | 287,235,125 | 301,966,810 |
| 其他非流动金融资产 | 92,458,403.81 | 346,396,575.38 | 283,595,630.49 | 282,005,000 |
| 固定资产 | 11,760,880,779.51 | 12,127,838,360.07 | 12,413,139,089.43 | 12,768,478,381.36 |
| 在建工程 | 1,857,196,033.58 | 1,285,969,127.79 | 585,392,295.97 | 343,559,937.21 |
| 使用权资产 | 3,033,518.65 | 2,330,281.28 | 3,165,323.87 | 4,007,321.13 |
| 无形资产 | 1,428,607,289.27 | 1,431,155,275.44 | 1,554,622,267.51 | 1,557,280,758.01 |
| 商誉 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 |
| 长期待摊费用 | 158,252,833.76 | 150,580,694.96 | 131,608,005.88 | 133,781,048.89 |
| 递延所得税资产 | 145,565,637.84 | 144,936,109.43 | 127,889,375.89 | 126,369,580.18 |
| 其他非流动资产 | 242,385,533.25 | 283,174,780.22 | 736,174,420.86 | 683,449,155.24 |
| 非流动资产合计 | 15,943,323,778.17 | 16,026,619,983.58 | 16,149,436,172.91 | 16,228,178,073.17 |
| 资产总计 | 26,171,422,640.9 | 26,785,425,436.3 | 25,968,669,338.11 | 25,915,976,725.38 |
| 流动负债: | | | | |
| 短期借款 | 2,048,194,588.49 | 1,831,796,712.9 | 1,836,557,738.45 | 1,800,136,227.43 |
| 衍生金融负债 | 41,757.62 | 42,227.58 | 1,397,055.38 | - |
| 应付票据及应付账款 | 4,208,824,520.53 | 4,078,627,753.51 | 3,301,240,263.1 | 3,512,238,291.61 |
| 其中:应付票据 | 2,460,783,784.89 | 2,259,312,216.46 | 1,837,586,180.32 | 1,777,053,969.91 |
| 应付账款 | 1,748,040,735.64 | 1,819,315,537.05 | 1,463,654,082.78 | 1,735,184,321.7 |
| 合同负债 | 1,118,970,354.31 | 656,266,656.92 | 888,573,512.63 | 746,778,983.64 |
| 应付职工薪酬 | 304,985,761.56 | 290,464,932.1 | 353,959,730.62 | 392,494,934.53 |
| 应交税费 | 179,099,642.03 | 212,820,799.37 | 207,407,622.64 | 194,688,876.58 |
| 其他应付款合计 | 181,566,504.48 | 1,437,537,640.7 | 274,629,079.38 | 256,349,893.68 |
| 应付股利 | 405,000 | 1,200,340,002.04 | 405,000 | 405,000 |
| 一年内到期的非流动负债 | 271,414,686.38 | 234,060,518.78 | 133,621,827.17 | 281,057,349.33 |
| 其他流动负债 | 85,618,146.56 | 46,050,129.71 | 84,259,349.64 | 79,369,933.52 |
| 流动负债合计 | 8,398,715,961.96 | 8,787,667,371.57 | 7,081,646,179.01 | 7,263,114,490.32 |
| 非流动负债: | | | | |
| 长期借款 | 1,685,721,702.78 | 1,957,357,123.82 | 2,080,063,223.85 | 1,918,679,223.83 |
| 租赁负债 | 225,171.2 | 482,287.52 | 741,108.63 | 1,012,966.64 |
| 长期应付款 | 20,853,592.07 | 23,457,549.63 | 24,382,278.26 | 10,500,000 |
| 长期应付职工薪酬 | - | - | 7,356,660.54 | 7,474,640.65 |
| 递延收益 | 347,014,575.9 | 345,546,673.63 | 357,269,446.28 | 367,624,988.38 |
| 递延所得税负债 | 4,112,521.87 | - | - | - |
| 非流动负债合计 | 2,057,927,563.82 | 2,326,843,634.6 | 2,469,812,717.56 | 2,305,291,819.5 |
| 负债合计 | 10,456,643,525.78 | 11,114,511,006.17 | 9,551,458,896.57 | 9,568,406,309.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,804,241,650 | 2,804,241,650 | 2,804,241,650 | 2,804,241,650 |
| 资本公积 | 33,749,867.59 | 33,749,867.59 | 33,749,867.59 | 33,749,867.59 |
| 减:库存股 | 39,999,676.57 | 39,999,676.57 | - | - |
| 其他综合收益 | -265,344,448.29 | -258,986,565.2 | -208,692,530.06 | -159,220,172.21 |
| 专项储备 | 6,041,016.25 | 6,174,999.62 | 6,184,039.44 | 4,992,619.68 |
| 盈余公积 | 1,379,865,682.01 | 1,379,865,682.01 | 1,379,865,682.01 | 1,379,865,682.01 |
| 未分配利润 | 11,796,225,024.13 | 11,745,868,472.68 | 12,401,861,732.56 | 12,283,940,768.49 |
| 归属于母公司股东权益合计 | 15,714,779,115.12 | 15,670,914,430.13 | 16,417,210,441.54 | 16,347,570,415.56 |
| 股东权益合计 | 15,714,779,115.12 | 15,670,914,430.13 | 16,417,210,441.54 | 16,347,570,415.56 |
| 负债和股东权益合计 | 26,171,422,640.9 | 26,785,425,436.3 | 25,968,669,338.11 | 25,915,976,725.38 |
| 公告日期 | 2026-10-31 | 2026-08-15 | 2026-04-22 | 2026-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |